The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third- line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial

Colaboración

Año: 2025

Secord, AA; Lewin, SN; Murphy, CG; Cecere, SC; Barquín, A; Gálvez-Montosa, F; Mathews, CA; Konecny, GE; Ray-Coquard, I; Oakni, A; Pérez, MJR; Bonaventura, A; Diver, EJ; Ayuk, SM; Wang, Y; Corr, BR; Salutari, V

Título: ANNALS OF ONCOLOGY

• D1